Dr. Amir M. Abolhoda

Dr. Abolhoda earned his medical degree from the University of California, Irvine, College of Medicine. He completed two residency programs, the first in general surgery at University of Medicine and Dentistry of New Jersey and the second in Cardiothoracic surgery at Montefiore Medical Center (Albert Einstein College of Medicine) in New York City. Dr. Abolhoda completed research and clinical fellowships in thoracic surgery at Memorial Sloan-Kettering Cancer Center in New York City. Dr Abolhoda performs a myriad of thoracic and foregut surgical procedures, using robotic techniques, including Robotic Lobectomy, Segmentectomy, Thymectomy and Hiatal hernia/anti-reflux operations. He also performs high risk Coronary Artery Bypass Grafting (off or on-pump) procedures, emergency Aortic Dissection Repairs and surgery for all types of Acquired Valvular Heart Disease.Dr. Abolhoda is a Diplomate of The American Board of Thoracic Surgery at the American Board of Surgery.  He leads the Thoracic Surgery Case Observation site at the Long Beach Memorial Medical Center, serving as a mentor for fellow thoracic surgeons on the Intuitive Surgical da Vinci XI to refine skills, learn new surgical modalities for minimally invasive thoracic procedures. Additionally, Dr. Abolhoda is a Health Sciences Clinical Professor for Surgery at the University of California, Irvine.In his free time, he enjoys playing tennis, watching soccer and spending time with family.Dr. Abolhoda performs minimally invasive cardiac and thoracic surgery including:Robotic MIDCABMinimally Invasive Aortic and Mitral Valve surgeriesRobotic Thoracic Operations.

Dr. Abolhoda is rated as an Experienced provider by MediFind in Coronary Artery Bypass Graft (CABG). His top areas of expertise are Pleuropulmonary Blastoma, Squamous Cell Lung Carcinoma, ALK-Positive Non-Small Cell Lung Cancer, Heart Bypass Surgery, and Thymectomy.

His clinical research consists of co-authoring 9 peer reviewed articles and participating in 1 clinical trial. MediFind looks at clinical research from the past 15 years.